Additionally, Anamorelin may also alleviate muscle wasting caused by cachexia by inhibiting the signaling of cytokines such as Myostatin, Activin-A, and TGF-β, which are considered important negative regulators of skeletal muscle mass. The gene discussed is TGFB1; the disease is Cachexia.